The Neuralert Team
The Neuralert team is deep in experience.
![Dr. Steven Messé, Co-founder](https://neuralertco03c8e.zapwp.com/q:lossless/r:0/wp:1/w:1/u:https://neuralert.co/wp-content/uploads/2022/11/messe.jpeg)
Dr. Steven Messé
Co-founder
Co-founder Dr. Messe is a board certified neurologist and runs Penn’s Center for Neuro-Cardio Protection. He is also the Chair of the American Hearty Association “Get With The Guidelines: Committee which establishes the protocols and guidelines used worldwide for stroke detection and treatment.
![Dr. James Weimer, Co-founder](https://neuralertco03c8e.zapwp.com/q:lossless/r:0/wp:1/w:1/u:https://neuralert.co/wp-content/uploads/2022/11/weimer.jpeg)
Dr. James Weimer
Co-founder
Jim Weimer. PhD is an expert in computer science, bioengineering, and signal processing. He has multiple PhDs and patents, and is the author of the Neuralert patented algorithm.
![Eric Corkhill, CEO](https://neuralertco03c8e.zapwp.com/q:lossless/r:0/wp:1/w:1/u:https://neuralert.co/wp-content/uploads/2022/11/corkhill.jpg)
Eric Corkhill
CEO
Eric Corkhill is the CEO of Neuralert. He is a 40-year veteran of the digital health industry and a serial entrepreneur helping five previous companies to successfully exit.
![Det Ansinn, CTO](https://neuralertco03c8e.zapwp.com/q:lossless/r:0/wp:1/w:1/u:https://neuralert.co/wp-content/uploads/2022/11/ansinn.jpeg)
Det Ansinn
CTO
Det Ansin is our acting CTO. Det oversees all of the software building, testing and system operation via his 85-person company BrickSimple, and has successfully developed and marketed multiple FDA approved mobile and wearable products.
![Bhavana Mohanraj, PhD, Assistant Director, PCI Ventures](https://neuralertco03c8e.zapwp.com/q:lossless/r:0/wp:1/w:1/u:https://neuralert.co/wp-content/uploads/2022/11/mohanraj.jpg)
Bhavana Mohanraj, PhD
Assistant Director, PCI Ventures
Bhavana Mohanraj, PhD manages a portfolio of life sciences companies acting as a key advisor to Neuralert. She partners with Penn faculty, researchers, and staff to build startups around innovative medical devices, therapeutics, and diagnostic technologies.